Territory Manager - Alabama, Mississippi, Fl Panhandle
Deciphera Pharmaceuticals
Summary
The Oncology Territory Manager is responsible for driving commercial performance within an assigned geographic territory by developing and maintaining professional relationships with oncology healthcare providers. This role executes brand strategy at the territory level through compliant, high-quality scientific and product education, supporting appropriate patient identification and access. The Oncology Territory Manager operates independently in the field while collaborating cross-functionally to deliver insights that inform business strategy, all in accordance with FDA regulations, company policies, and industry codes of conduct.
Job description
Key Responsibilities
Territory & Account Management (50%)
- Develop and execute a comprehensive territory business plan aligned with brand strategy, business objectives, and compliance requirements
- Identify, prioritize, and engage oncology accounts, including oncologists, advanced practice providers, pharmacists, and key office staff
- Deliver accurate, balanced, and approved product information, clinical data, and disease state education in a compliant manner
- Manage account interactions to support appropriate product utilization within approved indications
- Analyze territory performance data to adjust strategy and optimize call planning and resource allocation
Cross-Functional Collaboration & Field Insights (25%)
- Collaborate with Market Access, Medical Affairs, Sales Leadership, and other internal stakeholders to support patient access and education efforts
- Communicate field-based insights related to customer needs, market dynamics, competitive activity, and reimbursement trends
- Participate in internal meetings, training programs, and business reviews as required
Administrative, Reporting & Compliance Activities (20%)
- Maintain timely and accurate documentation of customer interactions, call activity, and territory plans within the CRM system
- Complete expense reporting, sample accountability (if applicable), and other administrative requirements in accordance with company policy
- Ensure strict adherence to FDA regulations, company SOPs, and industry compliance standards, including promotional practices
- Other duties and responsibilities as assigned
Qualifications
- Bachelor's degree required
- Minimum of 5+ years of pharmaceutical or biotechnology sales experience, with oncology experience required
- Demonstrated ability to work independently in a field-based role with limited supervision
- Strong understanding of compliant promotion within a regulated environment
- Valid driver's license and ability to travel extensively within the assigned territory
Preferred Capabilities
- Prior oncology specialty sales experience in a small-to-midsize biotech or emerging company environment
- Knowledge of oncology treatment landscapes, clinical pathways, and reimbursement considerations
- Proven ability to interpret data and translate insights into effective territory strategies
- Excellent communication, presentation, and relationship-building skills
- Strong organizational skills with the ability to manage multiple priorities effectively
Requirements
- Bachelor's degree required
- Minimum of 5+ years of pharmaceutical or biotechnology sales experience
- Oncology experience required
- Demonstrated ability to work independently in a field-based role with limited supervision
- Strong understanding of compliant promotion within a regulated environment
- Valid driver's license
- Ability to travel extensively within the assigned territory
Benefits
- Medical, Dental & Vision
- 401(k) Matching
- Life Insurance
- Flexible Spending Account
- Equity-Based Compensation
- Annual Performance Bonus
- Long-Term Incentive Plan
- Parental Leave
- Family Planning Benefits
Company overview
Deciphera Pharmaceuticals is a commercial-stage biopharmaceutical company headquartered in Waltham, Massachusetts, with research facilities in Lawrence, Kansas. Founded in 2003, the company specializes in discovering, developing, and commercializing innovative medicines for cancer treatment. As a member of the ONO Group since June 2024, Deciphera leverages its proprietary switch-control kinase inhibitor platform and deep expertise in kinase biology to develop a diverse portfolio of oncology therapeutics. The company's flagship product, QINLOCK®, is an approved switch-control inhibitor for fourth-line gastrointestinal stromal tumor (GIST), while its pipeline includes multiple clinical-stage candidates targeting various cancers and rare diseases. Deciphera's unique approach targets the switch pocket region of kinases, aiming to generate higher and more durable response rates compared to traditional kinase inhibitors. With a global presence spanning the United States, Europe, and Asia, the company maintains a patient-centric focus, developing transformational medicines to improve the lives of people living with cancer.